Latest statistics and disclosures from Syncona Portfolio's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ACHL, AUTL, FRLN, ADAP, and represent 100.00% of Syncona Portfolio's stock portfolio.
- Added to shares of these 1 stocks: FRLN (+$5.1M).
- Syncona Portfolio was a net buyer of stock by $5.1M.
- Syncona Portfolio has $105M in assets under management (AUM), dropping by -0.00%.
- Central Index Key (CIK): 0001725042
Tip: Access up to 7 years of quarterly data
Positions held by Syncona Portfolio consolidated in one spreadsheet with up to 7 years of dataDownload as csv Download as Excel
Portfolio Holdings for Syncona Portfolio
Companies in the Syncona Portfolio portfolio as of the March 2022 quarterly 13F filing
|Company (Ticker)||Portfolio Weight||Valued At||Change in Shares||Share Count||Share Price|
|Achilles Therapeutics Sponsored Ads (ACHL)||53.1||$56M||11M||5.01|
|Autolus Therapeutics Spon Ads (AUTL)||36.4||$38M||7.3M||5.19|
|Freeline Therapeutics Hldgs Sponsored Ads (FRLN)||5.6||$5.8M||+645%||22M||0.27|
|Adaptimmune Therapeutics Sponds Adr (ADAP)||4.9||$5.2M||1.4M||3.75|